Saturday, June 25th, 2022

Therapeutic Drug Monitoring Market Drivers and Research Report

The worldwide Therapeutic Drug Monitoring Market has recently been published by Absolute Markets Insights. The statistical report offers an appropriate analysis of recent trends and technological advancements in global regions such as North America, Latin America, Asia-Pacific, Africa, and India. The data also uses useful tools, methodologies and standard operating procedures carried out by top-level industries to support its analysis. Moreover, the study also applies effective exploratory techniques such as primary and secondary research techniques. Some of the distinctive market key components of the global Therapeutic Drug Monitoring market have been studied in order to get an extensive idea about the requirements of the businesses. Financial and economic aspects of the businesses have also been presented by means of graphical presentation techniques such as charts, graphs, tables, and pictures. The entire demand and supply chain has been explained with the help of penetrative insights into the businesses.

Top Players of Global Therapeutic Drug Monitoring Market are Studied: Abbot, Agilent Technologies, apDia Group, ARK Diagnostics, Inc., Beckman Coulter, Inc., bioMérieux S.A., Bio-Rad Laboratories, Inc., BioTeZ Berlin Buch GmbH, BÜHLMANN, Chromsystems Instruments & Chemicals GmbH, Exagen, Inc., F. Hoffmann-La Roche Ltd, Hamilton Company, Immundiagnostik AG, Quest Diagnostics Incorporated, Randox Laboratories Ltd., R-Biopharm AG, SEKISUI CHEMICAL CO., LTD., Siemens Healthcare Private Limited, THERADIAG, Thermo Fisher Scientific Inc. and UTAK amongst others.

Click to view the full report: https://www.absolutemarketsinsights.com/reports/Therapeutic-Drug-Monitoring-Market-2019-2027-686

The global therapeutic drug monitoring market was valued at US$ 1465.62 Mn in 2020 and is anticipated to witness a compound annual growth rate of +6.27% over the forecast period (2022-2030) owing to the significant rise in chronic diseases.  

The growing prevalence of cardiovascular disease amongst worldwide population coupled with the need for analyzing effects of drugs in these patients is driving the share of cardiac drugs in global therapeutic drug monitoring market. Fluorescence immunoassay technology contributed for a significant share of global therapeutic drug monitoring market owing to its high specificity, reliability and ease of handling.

North America accounted for the highest market share in global therapeutic drug monitoring market in 2018. The high presence of elderly and obese people, which are at high risk of medication errors, is creating demand for therapeutic drug monitoring and hence driving the share of North America region.

Global Therapeutic Drug Monitoring Market:

By Drugs

  • Antibiotics
  • Cardiac Drugs
  • Antiepileptics
  • Bronchodilators
  • Immunosuppressants
  • Anti-cancer drugs
  • Psychiatric drugs
  • Antiarrythmics
  • Others

By Products

  • Consumables
  • Equipment
  • Immunoassay Analyzers
  • Chromatography and MS Detectors
  • Others
  • Others

By Technology

  • Fluorescence Immunoassay
  • Chemiluminescent Immunoassays
  • Radioimmunassay
  • Thin Layer Chromatography
  • Radio immuno assay
  • Enzyme immune assay
  • Spectrophotometry and Fluorimetry
  • Others

By End Users

  • Hospitals & Clinics
  • Diagnostic centers
  • Research institutes
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Contact Us:

Contact Name: Shreyas Tanna

Company: Absolute Markets Insights

Email Id: [email protected]

Phone: IN +91-7400-24-24-24, US +1-510-420-1213

Website: www.absolutemarketsinsights.com

Leave a Reply

Your email address will not be published.